Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

ATHX

Athersys (ATHX)

Athersys Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ATHX
일자시간출처헤드라인심볼기업
2024/01/0821:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/12/2307:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/12/2201:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
2023/11/1622:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATHXAthersys Inc
2023/10/1821:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/10/1705:52Business WireAthersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic AlternativesNASDAQ:ATHXAthersys Inc
2023/10/1222:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/10/1122:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/10/1021:30Business WireAthersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with HealiosNASDAQ:ATHXAthersys Inc
2023/10/0706:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
2023/10/0706:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
2023/10/0405:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/10/0405:30Business WireAthersys Licenses its Animal Health Assets to Ardent Animal HealthNASDAQ:ATHXAthersys Inc
2023/10/0306:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/10/0306:04Business WireAthersys Director Jane Wasman Appointed Board ChairNASDAQ:ATHXAthersys Inc
2023/09/2605:36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATHXAthersys Inc
2023/09/2213:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ATHXAthersys Inc
2023/09/2001:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
2023/09/1910:35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ATHXAthersys Inc
2023/09/1910:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/09/1500:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
2023/09/1423:41Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
2023/09/1406:13Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ATHXAthersys Inc
2023/09/1121:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/09/0703:45Business WireGrant Awarded to Newcastle University to Research Athersys’ MultiStem® in Machine Perfusion Prior to Kidney TransplantationNASDAQ:ATHXAthersys Inc
2023/08/2203:36Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ATHXAthersys Inc
2023/08/1823:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/08/1810:30Business WireAthersys, Inc. Announces Pricing of $3.5 Million Public OfferingNASDAQ:ATHXAthersys Inc
2023/08/1805:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ATHXAthersys Inc
2023/08/1706:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATHXAthersys Inc
 검색 관련기사 보기:NASDAQ:ATHX